Is Landos Biopharma Inc (LABP) Stock a Bad Value Wednesday?

The 72 rating InvestorsObserver gives to Landos Biopharma Inc (LABP) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 72 percent of stocks in the Healthcare sector, LABP’s 72 overall rating means the stock scores better than 72 of all stocks.

LABP has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on LABP!

See Full LABP Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 72 means the stock is more attractive than 72 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Landos Biopharma Inc Stock Today?

Landos Biopharma Inc (LABP) stock is down -4.18% while the S&P 500 has gained 0.28% as of 12:36 PM on Wednesday, Nov 29. LABP is lower by -$0.19 from the previous closing price of $4.55 on volume of 25,021 shares. Over the past year the S&P 500 is higher by 15.41% while LABP has gained 89.57%. LABP lost -$3.81 per share the over the last 12 months. Click Here to get the full Stock Report for Landos Biopharma Inc stock.